Spark Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
74,567.00
293,530.60
296,165.80
520,167.20
453,606
Total Accounts Receivable
4,861.30
244.40
16,944.60
16,780.90
7,905.70
47,385
Other Current Assets
-
2,551.90
1,132.60
1,647.00
5,092.90
40,512
Total Current Assets
4,861.30
77,363.30
311,607.80
314,593.70
533,165.70
567,140
Net Property, Plant & Equipment
-
12,674.40
16,999.40
19,794.30
61,712.80
95,998
Total Investments and Advances
-
-
-
21,900.10
20,035.60
147,678
Intangible Assets
-
-
-
16,650.10
1,254.00
1,198
Other Assets
-
408.20
1,165.30
924.60
628.20
2,338
Total Assets
4,861.30
90,445.90
329,772.50
377,303.70
618,033.10
814,352
ST Debt & Current Portion LT Debt
-
-
-
302.00
312.00
Accounts Payable
-
2,676.70
9,687.60
9,928.70
14,182.80
Other Current Liabilities
1,492.50
13,177.50
12,428.10
19,766.80
39,191.70
Total Current Liabilities
1,492.50
15,854.20
22,115.70
29,997.50
53,686.50
Long-Term Debt
-
-
-
1,224.00
912.00
Deferred Taxes
-
-
-
1,000.20
-
Other Liabilities
-
19,385.90
17,119.10
11,364.30
48,573.60
Total Liabilities
1,492.50
35,240.10
39,234.70
47,027.00
104,408.90
Common Equity (Total)
6,631.20
27,231.50
290,537.80
330,276.70
513,624.20
Total Shareholders' Equity
3,368.80
55,205.70
290,537.80
330,276.70
513,624.20
Total Equity
3,368.80
55,205.70
290,537.80
330,276.70
513,624.20
Liabilities & Shareholders' Equity
4,861.30
90,445.90
329,772.50
377,303.70
618,033.10
Preferred Stock (Carrying Value)
10,000.00
82,437.20
-
-
-
About Spark Therapeutics
View Profile
